InnoVoyce

InnoVoyce is a private, commercial-stage medical device company focused on laser-based surgical tools. Founded in 2020 and based in San Francisco, the company has achieved FDA 510(k) clearance for its VYLO™ laser system and associated fibers, indicating it is now generating early revenue from commercial sales. With strong scientific founders from Harvard Medical and the Voice Health Institute, InnoVoyce is initially targeting the ENT and vocal health markets with a versatile platform technology that promises greater precision and control in soft tissue procedures.

VYLO™ 455nm blue light solid-state surgical laser platform, offering high power (up to 30W), multiple operational modes, and precise tissue targeting for soft tissue procedures, supported by proprietary laser fibers and accessories.

InnoVoyce competes in the surgical laser market against established players like Medtronic (with CO2 lasers), Stryker, and other specialized laser manufacturers. Its differentiation is based on the specific 455nm wavelength, high power in a solid-state system, and a focus on precision for delicate ENT procedures.